Publication Information

{'id': 'https://openalex.org/W2954806592', 'doi': 'https://doi.org/10.1158/1538-7445.am2019-3071', 'title': 'Abstract 3071: Repotrectinib demonstrates promising activities in <i>ROS1</i> wild-type and solvent-front mutant lung cancer patients-derived preclinical models', 'display_name': 'Abstract 3071: Repotrectinib demonstrates promising activities in <i>ROS1</i> wild-type and solvent-front mutant lung cancer patients-derived preclinical models', 'publication_year': 2019, 'publication_date': '2019-07-01', 'ids': {'openalex': 'https://openalex.org/W2954806592', 'doi': 'https://doi.org/10.1158/1538-7445.am2019-3071', 'mag': '2954806592'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2019-3071', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5014979322', 'display_name': 'Dong Hwi Kim', 'orcid': None}, 'institutions': [], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Dong Hwi Kim', 'raw_affiliation_strings': ['1Jeuk, Seoul, Republic of Korea;'], 'affiliations': [{'raw_affiliation_string': '1Jeuk, Seoul, Republic of Korea;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079701976', 'display_name': 'Seok-Young Kim', 'orcid': 'https://orcid.org/0000-0001-8566-839X'}, 'institutions': [], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Seok-Young Kim', 'raw_affiliation_strings': ['1Jeuk, Seoul, Republic of Korea;'], 'affiliations': [{'raw_affiliation_string': '1Jeuk, Seoul, Republic of Korea;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112760806', 'display_name': 'Hyeong Seok Joo', 'orcid': None}, 'institutions': [], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Hyeong Seok Joo', 'raw_affiliation_strings': ['1Jeuk, Seoul, Republic of Korea;'], 'affiliations': [{'raw_affiliation_string': '1Jeuk, Seoul, Republic of Korea;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023886728', 'display_name': 'You Won Lee', 'orcid': 'https://orcid.org/0000-0001-6334-5581'}, 'institutions': [{'id': 'https://openalex.org/I193775966', 'display_name': 'Yonsei University', 'ror': 'https://ror.org/01wjejq96', 'country_code': 'KR', 'type': 'education', 'lineage': ['https://openalex.org/I193775966']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'You Won Lee', 'raw_affiliation_strings': ['2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.'], 'affiliations': [{'raw_affiliation_string': '2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.', 'institution_ids': ['https://openalex.org/I193775966']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112382449', 'display_name': 'Han Na Kang', 'orcid': None}, 'institutions': [], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Han Na Kang', 'raw_affiliation_strings': ['1Jeuk, Seoul, Republic of Korea;'], 'affiliations': [{'raw_affiliation_string': '1Jeuk, Seoul, Republic of Korea;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011980528', 'display_name': 'Min Hee Hong', 'orcid': 'https://orcid.org/0000-0003-3490-2195'}, 'institutions': [{'id': 'https://openalex.org/I193775966', 'display_name': 'Yonsei University', 'ror': 'https://ror.org/01wjejq96', 'country_code': 'KR', 'type': 'education', 'lineage': ['https://openalex.org/I193775966']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Min Hee Hong', 'raw_affiliation_strings': ['2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.'], 'affiliations': [{'raw_affiliation_string': '2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.', 'institution_ids': ['https://openalex.org/I193775966']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047490140', 'display_name': 'Hye Ryun Kim', 'orcid': 'https://orcid.org/0000-0002-1842-9070'}, 'institutions': [{'id': 'https://openalex.org/I193775966', 'display_name': 'Yonsei University', 'ror': 'https://ror.org/01wjejq96', 'country_code': 'KR', 'type': 'education', 'lineage': ['https://openalex.org/I193775966']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Hye Ryun Kim', 'raw_affiliation_strings': ['2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.'], 'affiliations': [{'raw_affiliation_string': '2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.', 'institution_ids': ['https://openalex.org/I193775966']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064697305', 'display_name': 'Byoung Chul Cho', 'orcid': 'https://orcid.org/0000-0002-5562-270X'}, 'institutions': [{'id': 'https://openalex.org/I193775966', 'display_name': 'Yonsei University', 'ror': 'https://ror.org/01wjejq96', 'country_code': 'KR', 'type': 'education', 'lineage': ['https://openalex.org/I193775966']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Byoung Chul Cho', 'raw_affiliation_strings': ['2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.'], 'affiliations': [{'raw_affiliation_string': '2Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.', 'institution_ids': ['https://openalex.org/I193775966']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5113912325', 'display_name': 'Miran Yun', 'orcid': None}, 'institutions': [], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Miran Yun', 'raw_affiliation_strings': ['1Jeuk, Seoul, Republic of Korea;'], 'affiliations': [{'raw_affiliation_string': '1Jeuk, Seoul, Republic of Korea;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '79', 'issue': '13_Supplement', 'first_page': '3071', 'last_page': '3071'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9913, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.9851, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2779422266', 'wikidata': 'https://www.wikidata.org/wiki/Q5186964', 'display_name': 'Crizotinib', 'level': 4, 'score': 0.97695863}, {'id': 'https://openalex.org/C2775999482', 'wikidata': 'https://www.wikidata.org/wiki/Q18031208', 'display_name': 'ROS1', 'level': 4, 'score': 0.9304588}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5906701}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.5418499}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.53287905}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.48190883}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4605303}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.41147688}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.37467608}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3006299}, {'id': 'https://openalex.org/C2781182431', 'wikidata': 'https://www.wikidata.org/wiki/Q356033', 'display_name': 'Adenocarcinoma', 'level': 3, 'score': 0.26718855}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.1871405}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.16065642}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.112182885}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.070246994}, {'id': 'https://openalex.org/C2776232967', 'wikidata': 'https://www.wikidata.org/wiki/Q6743514', 'display_name': 'Malignant pleural effusion', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2019-3071', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.82, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3137317427', 'https://openalex.org/W3115657223', 'https://openalex.org/W2961707949', 'https://openalex.org/W2786715459', 'https://openalex.org/W2103447891', 'https://openalex.org/W2004137755', 'https://openalex.org/W1990626198', 'https://openalex.org/W1987801860', 'https://openalex.org/W1970822548', 'https://openalex.org/W1589805911'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 97], 'ROS1-rearranged': [2], 'non-small-cell': [3], 'lung': [4, 404], 'cancer': [5, 405], '(NSCLC)': [6], 'is': [7, 32], 'currently': [8], 'treated': [9], 'with': [10, 59, 163, 174, 267, 346, 363], 'ALK/ROS1': [11], 'tyrosine': [12], 'kinase': [13], 'inhibitor': [14], '(TKI)': [15], 'crizotinib': [16, 164, 226], 'as': [17, 66, 356, 358], 'a': [18, 317, 331], 'first-line': [19], 'agent.': [20], 'However,': [21], 'resistance': [22, 177], 'invariably': [23], 'develops': [24], 'and': [25, 71, 76, 83, 87, 100, 122, 135, 152, 165, 171, 206, 213, 218, 270, 286, 326, 401], 'subsequent': [26, 339], 'therapeutic': [27], 'option': [28, 343], 'for': [29, 344, 416], 'overcoming': [30], 'them': [31], 'limited.': [33], 'Therefore,': [34], 'we': [35, 51], 'investigated': [36], 'the': [37, 95, 114, 126, 148, 154, 189, 202, 211, 232, 240, 243, 274, 283, 353, 413], 'antitumor': [38, 103, 319], 'activity': [39, 288, 320], 'of': [40, 62, 105, 119, 156, 192, 204, 234, 242, 281, 289, 321, 412], 'several': [41], 'ROS1-TKIs': [42, 106, 182], 'in': [43, 98, 101, 107, 139, 188, 216, 219, 263, 294, 323, 398], 'ROS1-positive': [44, 347], 'patient-derived': [45, 54], 'preclinical': [46, 407], 'models.': [47], 'In': [48, 142, 228], 'this': [49], 'study,': [50], 'established': [52], '6': [53], 'cells': [55], '(PDCs)': [56], 'from': [57], 'patients': [58, 295, 345, 362], 'different': [60], 'types': [61], 'ROS1': [63, 205, 328, 399], 'fusion': [64], 'partners': [65], 'follows:': [67], 'treatment-naïve': [68], '(YU1078,': [69], 'YU1082': [70, 172], 'YU1083),': [72], 'crizotinib-resistant': [73], 'G2032R': [74, 224], '(YU1079)': [75], 'crizotinib-': [77], 'or': [78, 252, 302, 340], 'entrectinib-': [79], 'primary': [80, 176], 'resistant': [81], '(YU1081': [82], 'YU1085).': [84], 'Sanger': [85], 'sequencing': [86, 89], 'whole-exome': [88], 'were': [90, 110, 306], 'then': [91], 'conducted': [92], 'to': [93, 124, 178, 186], 'determine': [94], 'characteristics.': [96], 'vitro': [99, 217], 'vivo': [102, 220], 'activities': [104, 397], 'these': [108], 'PDCs': [109], 'evaluated': [111], 'by': [112], 'comparing': [113], 'survival,': [115], 'expression': [116], 'assay,': [117], 'duration': [118, 155], 'tumor': [120, 150, 157, 261], 're-emergence': [121, 158], 'ability': [123], 'penetrate': [125], 'blood-brain': [127], 'barrier': [128], '(BBB).': [129], 'Repotrectinib': [130, 394], 'potently': [131], 'inhibited': [132], 'cell': [133], 'proliferation': [134], 'ROS1-downstream': [136], 'signaling': [137], 'pathways': [138], 'YU1078': [140], '(CD74-ROS1).': [141], 'YU1078-derived': [143], 'xenograft': [144, 230], 'models,': [145, 231], 'repotrectinib': [146, 187, 199, 209, 235, 258, 322, 334], 'induced': [147, 259], 'marked': [149], 'regression': [151, 262], 'delayed': [153], 'following': [159], 'drug': [160, 248], 'withdrawal': [161], 'compared': [162], 'entrectinib.': [166], 'Interestingly,': [167], 'both': [168, 324], 'YU1081': [169], '(TPM3-ROS1)': [170], '(SLC34A2-ROS1)': [173], 'cross': [175], 'other': [179], 'clinically': [180], 'available': [181, 354], 'exhibited': [183], 'high': [184], 'sensitivity': [185], 'concentration': [190], 'range': [191], '100~200': [193], 'nM.': [194], 'Immunoblot': [195], 'analysis': [196], 'demonstrated': [197], 'that': [198, 333], 'completely': [200], 'suppressed': [201], 'phosphorylation': [203], 'STAT3.': [207], 'Notably,': [208], 'showed': [210], 'selective': [212], 'highly': [214], 'potency': [215], 'against': [221], 'solvent-front': [222, 402], 'mutant': [223, 327, 403], 'conferring': [225], 'resistance.': [227], 'G2032R-mutant': [229], 'response': [233], 'was': [236], 'still': [237], 'maintained': [238], 'until': [239], 'end': [241], 'experiment': [244], '(120': [245], 'days)': [246], 'after': [247], 'withdrawal,': [249], 'but': [250], 'loratinib-': [251], 'cabozantinib-treated': [253], 'tumors': [254], 'rapidly': [255], 're-emerged.': [256], 'Moreover,': [257], 'profound': [260], 'brain': [264], 'metastasis': [265], 'model': [266], 'excellent': [268], 'brain/plasma': [269], 'tumor/brain': [271], 'area': [272], 'under': [273], 'concentration-time': [275], 'curve': [276], 'value.': [277], 'As': [278], 'clinical': [279, 311], 'proof': [280], 'concept,': [282], 'potent': [284], 'systemic': [285], 'intracranial': [287], 'ropotrectinib': [290], 'has': [291], 'been': [292], 'observed': [293], 'who': [296, 305, 349], 'had': [297], 'progressed': [298], 'on': [299, 352], 'prior': [300], 'TKIs': [301, 355], 'TKI-naïve': [303], 'patients,': [304], 'enrolled': [307], 'on-going': [308], 'phase': [309], '1/2': [310], 'trial': [312], '(NCT03093116).': [313], 'Our': [314], 'finding': [315], 'indicated': [316], 'superior': [318], 'wild-type': [325, 400], 'fusion,': [329], 'providing': [330], 'rationale': [332], 'may': [335], 'be': [336], 'an': [337], 'effective': [338], 'upfront': [341], 'treatment': [342], 'NSCLC': [348], 'have': [350], 'relapsed': [351], 'well': [357], 'TKI': [359], 'naïve,': [360], 'including': [361], 'progressive': [364], 'CNS': [365], 'metastases.': [366], 'Citation': [367], 'Format:': [368], 'Dong': [369], 'Hwi': [370], 'Kim,': [371, 373, 388], 'Seok-Young': [372], 'Hyeong': [374], 'Seok': [375], 'Joo,': [376], 'You': [377], 'Won': [378], 'Lee,': [379], 'Han': [380], 'Na': [381], 'Kang,': [382], 'Min': [383], 'Hee': [384], 'Hong,': [385], 'Hye': [386], 'Ryun': [387], 'Byoung': [389], 'Chul': [390], 'Cho,': [391], 'Miran': [392], 'Yun.': [393], 'demonstrates': [395], 'promising': [396], 'patients-derived': [406], 'models': [408], '[abstract].': [409], 'In:': [410], 'Proceedings': [411], 'American': [414], 'Association': [415], 'Cancer': [417, 431], 'Research': [418], 'Annual': [419], 'Meeting': [420], '2019;': [421], '2019': [422], 'Mar': [423], '29-Apr': [424], '3;': [425], 'Atlanta,': [426], 'GA.': [427], 'Philadelphia': [428], '(PA):': [429], 'AACR;': [430], 'Res': [432], '2019;79(13': [433], 'Suppl):Abstract': [434], 'nr': [435], '3071.': [436]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2954806592', 'counts_by_year': [], 'updated_date': '2024-12-12T17:54:44.742180', 'created_date': '2019-07-12'}